Used in cancer research, particularly for prostate cancer. Acts as an endothelin A receptor antagonist, blocking signals that may promote tumor growth and progression. Investigated in clinical trials to evaluate its ability to slow disease advancement, especially in hormone-resistant or metastatic cases. Shows potential in reducing bone metastasis and improving survival outcomes when combined with other therapies. Also studied for effects on tumor angiogenesis and cell proliferation.